Construction and evaluation of the functional polygenic risk score for gastric cancer in a prospective cohort of the European population

被引:0
|
作者
Gu, Yuanliang [1 ,2 ]
Yan, Caiwang [2 ,3 ,4 ]
Wang, Tianpei [2 ]
Hu, Beiping [2 ]
Zhu, Meng [2 ,3 ,4 ,5 ]
Jin, Guangfu [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Southeast Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 210009, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatmen, Nanjing 211166, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Nanjing 211166, Jiangsu, Peoples R China
[5] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Jiangsu Key Lab Mol & Translat Canc Res,Affiliated, Nanjing 210009, Jiangsu, Peoples R China
[6] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Polygenic risk score; Gastric cancer; Polymorphism; single nucleotide; Cross ancestry; GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; GENETIC RISK; PREDICTION; VARIANTS; ANNOTATION; MUTATIONS; FRAMEWORK;
D O I
10.1097/CM9.0000000000002716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:A polygenic risk score (PRS) derived from 112 single-nucleotide polymorphisms (SNPs) for gastric cancer has been reported in Chinese populations (PRS-112). However, its performance in other populations is unknown. A functional PRS (fPRS) using functional SNPs (fSNPs) may improve the generalizability of the PRS across populations with distinct ethnicities. Methods:We performed functional annotations on SNPs in strong linkage disequilibrium (LD) with the 112 previously reported SNPs to identify fSNPs that affect protein-coding or transcriptional regulation. Subsequently, we constructed an fPRS based on the fSNPs by using the LDpred2-infinitesimal model and then analyzed the performance of the PRS-112 and fPRS in the risk prediction of gastric cancer in 457,521 European participants of the UK Biobank cohort. Finally, the performance of the fPRS in combination with lifestyle factors were evaluated in predicting the risk of gastric cancer. Results:During 4,582,045 person-years of follow-up with a total of 623 incident gastric cancer cases, we found no significant association between the PRS-112 and gastric cancer risk in the European population (hazard ratio [HR] = 1.00 [95% confidence interval (CI) 0.93-1.09], P = 0.846). We identified 125 fSNPs, including seven deleterious protein-coding SNPs and 118 regulatory non-coding SNPs, and used them to construct the fPRS-125. Our result showed that the fPRS-125 was significantly associated with gastric cancer risk (HR = 1.11 [95% CI, 1.03-1.20], P = 0.009). Compared to participants with a low fPRS-125 (bottom quintile), those with a high fPRS-125 (top quintile) had a higher risk of incident gastric cancer (HR = 1.43 [95% CI, 1.12-1.84], P = 0.005). Moreover, we observed that participants with both an unfavorable lifestyle and a high genetic risk had the highest risk of incident gastric cancer (HR = 4.99 [95% CI, 1.55-16.10], P = 0.007) compared to those with both a favorable lifestyle and a low genetic risk. Conclusion:These results indicate that the fPRS-125 derived from fSNPs may act as an indicator to measure the genetic risk of gastric cancer in the European population.
引用
收藏
页码:1671 / 1679
页数:9
相关论文
共 50 条
  • [41] Association of smoking and polygenic risk with the incidence of lung cancer: a prospective cohort study
    Zhang, Peidong
    Chen, Pei-Liang
    Li, Zhi-Hao
    Zhang, Ao
    Zhang, Xi-Ru
    Zhang, Yu-Jie
    Liu, Dan
    Mao, Chen
    BRITISH JOURNAL OF CANCER, 2022, 126 (11) : 1637 - 1646
  • [42] A Polygenic Risk Score for Prostate Cancer Risk Prediction
    Schaffer, Kerry R.
    Shi, Mingjian
    Shelley, John P.
    Tosoian, Jeffrey J.
    Kachuri, Linda
    Witte, John S.
    Mosley, Jonathan D.
    JAMA INTERNAL MEDICINE, 2023, 183 (04) : 386 - 388
  • [43] Breast cancer risk assessment combined with a polygenic risk score in the general population for personalized screening
    Saghatchian, Mahasti
    Abehsera, Marc
    Sigal, Robert
    Gauthier, Emilien
    Helin, Valerie
    Villoing-Gaude, Laure
    Reyes, Cecile
    Rapinat, Audrey
    Gentien, David
    Golmard, Lisa
    Stoppa-Lyonnet, Dominique
    CANCER RESEARCH, 2021, 81 (04)
  • [44] Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan
    Hara, Azusa
    Sasazuki, Shizuka
    Inoue, Manami
    Iwasaki, Motoki
    Shimazu, Taichi
    Sawada, Norie
    Yamaji, Taiki
    Tsugane, Shoichiro
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 95 (01): : 147 - 154
  • [45] Polygenic Risk Score in Predicting Esophageal, Oropharyngeal, and Hypopharynx Cancer Risk among Taiwanese Population
    Huang, Yu-Che
    Lee, Ming-Ching
    Huang, Sheng-Yang
    Chou, Chia-Man
    Yang, Hui-Wen
    Chen, I-Chieh
    CANCERS, 2024, 16 (04)
  • [46] Interactions of a polygenic risk score and modifiable lifestyle factors for breast cancer in the Multiethnic Cohort
    Chou, Alisha
    Chen, Fei
    Wan, Peggy
    Sheng, Xin
    Park, Song-Yi
    Stram, Daniel O.
    Wilkens, Lynne R.
    Le Marchand, Loic
    Haiman, Christopher A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (01) : 300 - 301
  • [47] Polygenic risk score for atopic dermatitis in the Canadian population
    Simard, Mathieu
    Madore, Anne-Marie
    Girard, Simon
    Waserman, Susan
    Duan, Qingling
    Subbarao, Padmaja
    Sears, Malcolm R.
    Moraes, Theo J.
    Becker, Allan B.
    Turvey, Stuart E.
    Mandhane, Piushkumar J.
    Morin, Charles
    Begin, Philippe
    Laprise, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (01) : 406 - +
  • [48] Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort
    Wu, Yishuo
    Ruan, Xiaohao
    Gao, Peng
    Da, Huang
    Fang, Zujun
    Xu, Danfeng
    Jiang, Haowen
    Ding, Qiang
    Lin, Xiaoling
    Lu, Daru
    Na, Rong
    CLINICAL GENETICS, 2023, 103 (06) : 636 - 643
  • [49] Polygenic risk score for precision cancer prevention
    Okada, Yukinori
    CANCER SCIENCE, 2023, 114 : 1529 - 1529
  • [50] Validation of a prostate cancer polygenic risk score
    Black, Mary H.
    Li, Shuwei
    LaDuca, Holly
    Lo, Min-Tzu
    Chen, Jefferey
    Hoiness, Robert
    Gutierrez, Stephanie
    Tippin-Davis, Brigette
    Lu, Hsiao-Mei
    Gielzak, Marta
    Wiley, Kathleen
    Shi, Zhuqing
    Wei, Jun
    Zheng, Siqun Lilly
    Helfand, Brian T.
    Isaacs, William
    Xu, Jianfeng
    PROSTATE, 2020, 80 (15): : 1314 - 1321